Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)
Clinical trial NCT00722592 · COMPLETED
Trial details
- NCT number
- NCT00722592
- Sponsor
- Endocyte
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2010-09-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.